LeJeune Puetz Investment Counsel’s Biogen BIIB Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$126K	Hold	452	–	–	0.05%	187
2022 Q4	$125K	Hold	452	–	–	0.05%	185
2022 Q3	$121K	Buy	+452	New	+$96K	0.05%	180
2022 Q1	–	Sell	-452	Closed	-$108K	–	193
2021 Q4	$108K	Hold	452	–	–	0.04%	192
2021 Q3	$128K	Hold	452	–	–	0.05%	184
2021 Q2	$157K	Hold	452	–	–	0.06%	172
2021 Q1	$126K	Hold	452	–	–	0.05%	179
2020 Q4	$111K	Hold	452	–	–	0.05%	178
2020 Q3	$128K	Hold	452	–	–	0.06%	160
2020 Q2	$121K	Hold	452	–	–	0.06%	157
2020 Q1	$143K	Hold	452	–	–	0.08%	150
2019 Q4	$134K	Hold	452	–	–	0.06%	164
2019 Q3	$105K	Hold	452	–	–	0.05%	174
2019 Q2	$106K	Sell	452 -25	-5%	-$5.77K	0.05%	176
2019 Q1	$113K	Buy	+477	New	+$150K	0.06%	164
2018 Q4	–	Sell	-302	Closed	-$107K	–	169
2018 Q3	$107K	Buy	+302	New	+$104K	0.06%	162

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LeJeune Puetz Investment Counsel's BIIB Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel held its Biogen (BIIB) position steady in Q1 2023 at 452 shares worth $126K. The position accounts for 0.05% of the portfolio, ranked #187.

LeJeune Puetz Investment Counsel first reported a position in BIIB in Q3 2018 and has held it in 16 quarters since. The position peaked at $157K in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

LeJeune Puetz Investment Counsel held 452 shares of Biogen worth $126K as of Q1 2023.
LeJeune Puetz Investment Counsel left its Biogen share count unchanged in Q1 2023.
Biogen made up 0.05% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #187 holding.
LeJeune Puetz Investment Counsel first reported a position in Biogen in Q3 2018 and has held it in 16 quarters since.
LeJeune Puetz Investment Counsel's Biogen position peaked at $157K in Q2 2021.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.